DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elitek (Rasburicase) - Current Clinical Trials


Elitek Related Clinical Trials

Rasburicase in Patients at Risk for Tumor Lysis Syndrome [Completed]

Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS [Completed]

Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies [Terminated]

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 [Recruiting]

Fasturtec TLS Treatment / Prophylysis [Completed]

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma [Completed]

Rasburicase for Hyperuricemia [Completed]

Rasburicase in Tumor Lysis Syndrome [Completed]

Elitek (Rasburicase) Immuno-Monitoring Study [Terminated]

Lowering Serum Uric Acid to Prevent Acute Kidney Injury [Completed]

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome [Completed]

Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma [Completed]

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients [Completed]

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Completed]

Rasburicase (Fasturtec) Registration Trial [Terminated]

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma [Terminated]

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome [Completed]

Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma [Completed]

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy [Completed]

Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status [Completed]

Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia [Completed]

The Relationship Between Uric Acid and Inflammatory Markers [Completed]

Mature B-Cell Lymphoma And Leukemia Study III [Recruiting]

Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout [Completed]

A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program [Not yet recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017